Cargando…
Novel sulphonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers
A series of sulphonamide benzoquinazolinones 5–18 was synthesized and evaluated for cytotoxic activity against MDA-MB-231 cell line. The compounds showed IC(50) ranging from 0.26 to 161.49 µM. The promising compounds were evaluated for their inhibitory profile against epidermal growth factor (EGFR)...
Autores principales: | Soliman, Aiten M., Alqahtani, Ali S., Ghorab, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522976/ https://www.ncbi.nlm.nih.gov/pubmed/31074303 http://dx.doi.org/10.1080/14756366.2019.1609469 |
Ejemplares similares
-
Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers
por: Ghorab, Mostafa M., et al.
Publicado: (2020) -
Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors
por: Ghorab, Mostafa M., et al.
Publicado: (2017) -
Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and in silico studies
por: Alqahtani, Ali S., et al.
Publicado: (2021) -
Novel N-(Substituted) Thioacetamide Quinazolinone Benzenesulfonamides as Antimicrobial Agents
por: Ghorab, Mostafa M, et al.
Publicado: (2020) -
VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo[g]quinazolin bearing benzenesulfonamide moiety
por: Ghorab, Mostafa M., et al.
Publicado: (2017)